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Abstract
Genome-wide association studies of lung cancer reported in populations of European background have identified three
regions on chromosomes 5p15.33, 6p21.33, and 15q25 that have achieved genome-wide significance with p-values of 10
27
or lower. These studies have been performed primarily in cigarette smokers, raising the possibility that the observed
associations could be related to tobacco use, lung carcinogenesis, or both. Since most women in Asia do not smoke, we
conducted a genome-wide association study of lung adenocarcinoma in never-smoking females (584 cases, 585 controls)
among Han Chinese in Taiwan and found that the most significant association was for rs2736100 on chromosome 5p15.33
(p=1.30610
211). This finding was independently replicated in seven studies from East Asia totaling 1,164 lung
adenocarcinomas and 1,736 controls (p=5.38610
211). A pooled analysis achieved genome-wide significance for rs2736100.
This SNP marker localizes to the CLPTM1L-TERT locus on chromosome 5p15.33 (p=2.60610
220, allelic risk=1.54, 95%
Confidence Interval (CI) 1.41–1.68). Risks for heterozygote and homozygote carriers of the minor allele were 1.62 (95% CI;
1.40–1.87), and 2.35 (95% CI: 1.95–2.83), respectively. In summary, our results show that genetic variation in the CLPTM1L-
TERT locus of chromosome 5p15.33 is directly associated with the risk of lung cancer, most notably adenocarcinoma.
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Introduction
To date, several large genome-wide association studies (GWAS)
of lung cancer conducted in subjects of European background
have identified susceptibility alleles on chromosomes 5p15.33,
6p21.33 and 15q25 [1–8]. These studies have shown that
statistical evidence that exceeds the threshold of genome wide
significance, defined as a p value less than 5610
27 [9] or 1610
28
[10]. In each study, the majority of cases and controls were
cigarette smokers, making it difficult to determine whether these
loci are associated with lung carcinogenesis or tobacco use, or
perhaps both [11]. It has been difficult to accrue a sufficiently large
set of lung cancer cases with no history of smoking because a high
proportion of lung cancer in women as well as men in North
America and Europe is directly related to tobacco use. In contrast,
a substantial proportion of lung cancer in East Asian women
occurs among non-smokers, who interestingly have a relatively
high rate of lung cancer [12]. This suggests that genetic and/or
environmental factors could account for the observed differences.
To investigate this further, we conducted a genome-wide asso-
ciation study with follow-up of notable SNPs in never-smoking
women in East Asia. In addition, we genotyped tag SNPs
optimized for East Asians for the three regions previously
identified by GWAS in European populations.
Results
Genome-wide association scan
We conducted an initial GWAS of 584 lung cancer cases and
585 controls drawn from a case-control study in Taiwan, the
Genetic Epidemiological Study of Lung Adenocarcinoma (GE-
LAC) [13] (Table 1). Cases were restricted to those never-smoking
females with a confirmed diagnosis of adenocarcinoma of the lung
in GELAC. Controls were drawn from never-smoking female
controls in GELAC and frequency-matched by age with cases (see
Text S1 for more details). We began with a pilot study in which 54
cases and 54 controls were genotyped with the Illumina
HumanCNV370-Duo BeadChip and, based on its success, 550
cases and 549 controls were genotyped on the Illumina
HumanHap 610 Quad BeadChip. After quality control metrics
were applied to both data sets (see Materials and Methods), the
variance inflation factor l in the genomic control model was found
to be 1.013 and the inflation factor l1000 for an equivalent study of
1000 cases and controls [14] was 1.022; together with the
comparison of the observed and expected p-values in the quantile-
quantile plot, shown in Figure 1, there is no evidence of a
substantial issue related to population substructure but instead,
several promising regions in the tail of the distribution are
apparent, suitable for follow-up analysis. In fact, the distribution of
the bottom 90% of p-values is similar to the expected distribution
(Figure 1A) whereas the top 10% p-values displayed a deviation
consistent with possible new signals (Figure 1B).
As shown in Figure 1C, the scatter plot of p-values on a 2log
scale for the trend test conducted for 457,504 SNPs used after
quality control metrics were applied, only one SNP, rs2736100,
was highly associated with lung cancer (p=1.30 * 10
211) below the
threshold of genome-wide significance, namely, p less than
1610
27 (Figure 2). In an analysis for trend adjusted for age, the
allelic odds ratio was 1.83 (1.54–2.18), which is notably higher
than the estimates reported in the European studies (Figure 2) [4].
It is remarkable that our finding suggests a higher estimated effect
size compared to that which was reported in Europeans, who were
primarily smokers. To confirm the signal at rs2736100, the
samples in the GWAS were genotyped using an optimized
TaqMan assay (ABI, Foster City, CA), which had a concordance
of 99.7% between the two platforms [15].
Replication of the association of rs2736100 with lung
cancer risk
Replication of the strongest signal, rs2736100 was performed in
the remaining subjects of the GELAC study [13] as well as six
studies of never-smoking Asian women with lung adenocarcinoma
in East Asia. A total of 1164 cases with lung adenocarcinoma and
1736 controls were genotyped using an optimized TaqMan assay
(shown to have high concordance with the Illumina results as
described above). The additional replication studies included the
Chinese Academy of Medical Sciences Cancer Hospital study
(CAMSCH) [16], Wuhan lung cancer study (WHLCS) [17], Seoul
National University study (SNU) [18], Korea University Medical
Center study (KUMC) [19], Kyungpook National University
Hospital study (KNUH) [20] and Shanghai Women’s Health
5p15.33 and Risk of Lung Cancer in Never-Smokers
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study subjects from the GWAS and the replication studies are
presented in Table 1.
The combined replication study confirmed that rs2736100 is
associated with risk for lung adenocarcinoma in never-smoking
women in East Asia (p=5.38 * 10
211; allelic OR=1.44; 95% CI
1.29–1.60) (Figure 2). In a pooled analysis of the GWAS and
replication studies, rs2736100 was conclusively associated with the
risk for lung adenocarcinoma in never-smoking females in East
Asian populations; the allelic OR is 1.54 (95% CI 1.41–1.68;
p=2.60 * 10
220) (Figure 2 and Table 2). The estimated odds ratios
for the heterozygous and homozygous carriers are 1.62 (95% CI
1.40–1.87) and 2.35 (95% CI 1.95–2.83). There was no evidence
of heterogeneity between the results of the one cohort study
(SWHS) and the pooled analysis of the 6 case-control studies
(p=0.36). Further pooling with two previously published studies,
the Nanjing lung cancer study (NJLCS) [23] and the Genes and
Environment in Lung Cancer, Singapore study (GEL-S) [24,25]
(Table 1, Table S1), yielded comparable results (p=1.16 * 10
221)
(Table S2, Figure S1). Across all studies, we observed consistently
increased risk associated with rs2736100 with no evidence for
heterogeneity between studies, measured by the I
2 test for
heterogeneity (Figure S1). In a subsequent analysis combining all
lung cancer cases, rs2736100 was also significantly associated with
lung cancer susceptibility (p=5.50 * 10
220; allelic OR=1.48;
95% CI 1.36–1.62) (Table 2). This observation is comparable to
what is being reported for adenocarcinoma alone, which is not
surprising because adenocarcinomas constitute 76% of cases
(Table 2).
We conducted a first generation fine mapping of this region of
chromosome 5p15.33 using 15 tag SNPs optimized in the East
Asian studies in HapMap phase 2; the 15 SNPs were chosen using
an r
2$0.8 as a threshold and estimated to cover approximately
85% of the known SNPs in HapMap phase 2 (Table S3). We did
not identify stronger signals for association with lung adenocar-
cinoma in the 15 SNPs, as shown in Figure 3 and Table S4.
Notably, rs402710, previously reported in GWAS of European
ancestry [4], was the second most significant SNP tested in this
region but did not achieve genome-wide significance (p=0.0046)
(Table S4). When rs402710 and rs2736100 were analyzed in a
multivariable model, the former became non-significant (p=0.33).
Discussion
In this study of lung adenocarcinoma in East Asian never-
smoking women, we report a highly significant association with the
common SNP, rs2736100, which localizes to the TERT-
CLPTM1L locus on chromosome 5p15.33. Our study is notable
because the sample size for never-smoking female cases is
substantially larger than previous reports. Moreover, the estimated
effect size observed for rs2736100 and adenocarcinoma of the lung
Author Summary
Worldwide, approximately 15% of lung cancer cases occur
among nonsmokers. Genome-wide association studies
(GWAS) of lung cancer conducted in populations of
European background have identified three regions on
chromosomes 5, 6, and 15 that harbor genetic variants
that confer risk for lung cancer. Prior studies were
conducted primarily in cigarette smokers, raising the
possibility that the associations could be related to
tobacco use, lung carcinogenesis, or both. A GWAS of
lung cancer among never-smokers is an optimal setting to
discover effects that are independent of smoking. Since
most women in Asia do not smoke, we conducted a GWAS
of lung adenocarcinoma among never-smoking females
(584 cases, 585 controls) in Taiwan, and observed a region
on chromosome 5 significantly associated with risk for
lung cancer in never-smoking women. The finding was
independently replicated in seven studies from East Asia
totaling 1,164 lung adenocarcinomas and 1,736 controls.
To our knowledge, this study is the first reported GWAS of
lung cancer in East Asian women, and together with the
replication studies represents the largest genetic associa-
tion study in this population. The findings provide insight
into the genetic contribution of common variants to lung
carcinogenesis.
Table 1. Number of cases and controls, and study characteristics, for each participating study center.
Cases Controls Age [mean (std)]
Study Center{ Region (n=2768) (n=3100) Controls cases Study Design
GELAC Taiwan (GWAS) 584 585 58.9 (11.2) 59.0 (11.4) Case-control
GELAC Taiwan (replication) 610 560 57.0 (13.8) 60.1 (11.6) Case-control
CAMSCH Mainland China 287 287 56.3 (11.6) 56.3 (10.0) Case-control
SNU South Korea 259 293 61.2 (10.2) 61.2 (10.5) Case-control
SWHS Mainland China 209 213 58.9 (8.4) 58.9 (8.3) Cohort
WHLCS Mainland China 207 207 56.9 (9.6) 56.3 (11.2) Case-control
KNUH South Korea 121 119 60.7 (6.5) 61.1 (9.4) Case-control
KUMC South Korea 95 87 60.9 (6.4) 62.7 (10.5) Case-control
GEL-S* Singapore 193 546 64.7 (11.4) 63.4 (12.1) Case-control
NJLCS* Mainland China 203 203 56.9 (9.8) 56.8 (9.7) Case-control
{GELAC: Genetic Epidemiological Study of Lung Adenocarcinoma (in Taiwan); CAMSCH: Chinese Academy of Medical Sciences Cancer Hospital Study; SNU: Seoul
National University study; SWHS: Shanghai Women’s Health Cohort Study; WHLCS: Wuhan Lung Cancer Study; KNUH: Kyungpook National University Study; KUMC:
Korea University Study; GEL-S: Genes and Environment in Lung Cancer, Singapore study; NJLCS: Nanjing Lung Cancer Study.
*A subset of data presented in this paper for CAMSCH (Wu et al., (2009) Cancer Res;12:5065–5072), GEL-S (Truong et al., (2010) J Natl Cancer Inst, In press ), and NJLCS
(Jin et al., (2009) Carcinogenesis;30:987–990;Wu et al., (2009) Cancer Res;12:5065–5072) was previously published and is noted in Tables S1, S2, S4, S6 and Figure S1.
doi:10.1371/journal.pgen.1001051.t001
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European populations (e.g., OR=1.24 from the largest meta-
analysis reported to date [4,8], p=0.000046 for difference). Our
study provides strong evidence that this locus on chromosome
5p15.33 is directly related to lung carcinogenesis because it has
been conclusively shown in non-smoking women.
The SNP marker, rs2736100, is mapped to a region of
chromosome 5p15.33 in which common and rare genetic variants
Figure 1. Genome-wide association results in the GELAC study. (A) Quantile-quantile plot for lower 90% of 2log P-values, (B) upper 10% of
2log P-values, and (C) scatter plot of P-values in2log scale from the trend test for 457,504 genotyped variants comparing 584 cases and 585 controls.
doi:10.1371/journal.pgen.1001051.g001
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rs2736100 is localized to intron 2 of the telomerase gene TERT,a
reverse transcriptase that is critical for telomere replication and
stabilization by controlling telomere length. Variants in the TERT-
CLPTM1L locus have been identified by GWAS to harbor
susceptibility alleles for cancer of the brain, pancreas and lung
[8,26,27]. For the latter, a large meta-analysis combined with a
new scan indicates that the signal in this locus is most strongly
associated with one histology, adenocarcinoma in studies of
European subjects [8].
There is further evidence for association of this locus with
additional cancers, though the reported results have not yet
achieved the genome-wide association threshold; these include
cancer of the bladder, prostate, uterine cervix, and skin including
basal cell carcinoma and melanoma [4,5,7,27]. Rare variations/
mutations in the TERT gene have been described as a risk
factor for acute myelogenous leukemia and also explain a pro-
portion of the inherited bone marrow failure family pedigrees with
dyskeratosis congenita, a cancer predisposition syndrome [28,29].
Mutations in the TERT gene have also been described in patients
with idiopathic pulmonary fibrosis [30,31]. Together these
findings suggest that the TERT-CLPTM1L 5p15.33 region could
be important in the development of a spectrum of cancers. Still, at
this time, further studies are needed to fine map the region, based
on comprehensive re-sequence analysis in East Asian populations,
to narrow the set of genetic variants worthy of functional studies to
establish the mechanism underpinning the association marked by
the SNP rs2736100 and subsequently compare these findings with
comparable analyses in the other diseases.
The plausible mechanisms underlying the association signals
across this region of chromosome 5p15.33 are currently under
active investigation by many groups. Our findings are particularly
interesting because we have identified variants that appear to be
Table 2. Lung cancer risk associated with rs2736100, among
never-smoking females from East Asia, by histology.
Genotype Controls % Cases % OR{ 95%CI{ p-value
all lung cancers
TT 852 36.7 599 26.0
GT 1132 48.8 1187 51.4 1.49 1.30–1.70 3.76E-09
GG 337 14.5 522 22.6 2.20 1.85–2.62 2.94E-19
trend 2321 2308 1.48 1.36–1.62 5.50E-20
adenocarcinomas
TT 852 36.7 428 24.5
GT 1132 48.8 922 52.7 1.62 1.40–1.87 8.51E-11
GG 337 14.5 398 22.8 2.35 1.95–2.83 3.05E-19
trend 2321 1748 1.54 1.41–1.68 2.60E-20
squamous cell carcinomas
TT 852 36.7 60 33.9
GT 1132 48.8 82 46.3 1.02 0.72–1.44 0.91
GG 337 14.5 35 19.8 1.47 0.95–2.27 0.084
trend 2321 177 1.18 0.95–1.48 0.14
{Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and study
center.
doi:10.1371/journal.pgen.1001051.t002
Figure 2. Risk of lung adenocarcinoma associated with rs2736100 for never-smoking female cases and never-smoking female
controls from East Asia. Forest plot representing lung adenocarcinoma risk and the rs2736100 genotype. Odds ratios (OR) and 95% confidence
intervals (CI) for lung adenocarcinoma are derived from the per-allele model. All models are adjusted for age and study center. GELAC: Genetic
Epidemiological Study of Lung Adenocarcinoma (in Taiwan); CAMSCH: Chinese Academy of Medical Sciences Cancer Hospital Study; SNU: Seoul
National University study; SWHS: Shanghai Women’s Health Cohort Study; WHLCS: Wuhan Lung Cancer Study; KNUH: Kyungpook National University
Study; KUMC: Korea University Study.
doi:10.1371/journal.pgen.1001051.g002
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critical that future studies evaluate environmental risk factors that
may contribute, particularly since there is preliminary data
suggesting that smoking as well as other exposures could directly
influence telomere lengths [32]. It is noteworthy that lung cancer
risk among non-smoking women in East Asia has been linked to
indoor air pollution from environmental tobacco smoke [12],
fumes produced by high temperature cooking [33], and coal
combustion products [34].
Based on the discovery of susceptibility loci on chromosomal
regions 6p21.33 and 15q25 first observed in European populations
[1–3,35], we attempted to replicate the findings in never-smoking
women in East Asia. The strongest SNPs reported in each region
plus additional tag SNPs, chosen on the basis of HapMap Phase 2,
were genotyped in seven studies. 15 SNPs were selected for
6p21.33, covering an estimated 93% of known SNPs in HapMap
phase 2 in the East Asian populations, whereas 24 SNPs were
genotyped across 15q25, covering an estimated 83% of known
common SNPs in the region (Table S3). In these East Asian never-
smoking women, there was no convincing evidence for association
at chromosome 6p21.33 or for 15q25 for lung cancer overall or for
the adenocarcinoma subtype (Tables S5 and S6).
Figure 3. LD structure and association results for the chr5p15 region and lung adenocarcinoma. LD structure and regional association
results for 15 SNPs genotyped in the 5p15 region. SNPs included were tagged with r2$0.8 in HapMap CHB [37].
doi:10.1371/journal.pgen.1001051.g003
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the TERT-CLPTM1L locus on chromosome 5p15.33 are associ-
ated with risk for lung adenocarcinoma in non-smoking Asian
women. We observed estimated effect sizes that are substantially
higher than those previously reported in European smokers, which
bears follow-up investigation into the biology of the underlying
mechanism of the contribution of this region to primary lung
carcinogenesis. Since this region on chromosome 5p15.33 has
been implicated in many cancers, our observations should
stimulate further investigation of the region that could lead to
new insights into carcinogenesis.
Materials and Methods
Studies
A description of each study is provided in Table 1 and Text S1.
Lung cancer cases and controls for the GWAS were drawn from
the Genetic Epidemiological Study of Lung Adenocarcinoma
(GELAC) in Taiwan. A total of 584 never-smoking incident cases
and 585 never-smoking controls were included in the GWAS. The
replication studies were drawn from seven studies, including
additional subjects from the GELAC study [13], the Chinese
Academy of Medical Sciences Cancer Hospital study (CAMSCH)
[16], the Wuhan lung cancer study (WHLCS) [17], the Seoul
National University study (SNU) [18], the Korea University
Medical Center study (KUMC) [19], the Kyungpook National
University Hospital study (KNUH) [20], and the Shanghai
Women’s Health Cohort Study (SWHS) [21,22]. In addition,
data were pooled with previously published findings from the
Nanjing lung cancer study (NJLCS) [23] and the Genes and
Environment in Lung Cancer, Singapore study (GEL-S) [24]
(Table 1). All studies are case-control studies with the exception of
the SWHS, which is a prospective cohort study. The range of ages
is similar in cases and controls across all studies (Table 1).
Ethics statement
All study subjects provided informed consent and each study
was approved by its respective institution’s IRB.
Genotyping and quality control
Genome-wide association study genotyping and quality
control. GWAS genotyping of the GELAC samples was
performed in two separate phases. In the pilot phase, 54 cases
and 54 controls were genotyped by GeneTech Biotech Co.,
(Taiwan), using the Illumina HumanCNV370-Duo BeadChip.
The cases were never-smoking females diagnosed with lung
adenocarcinoma at age #51 who had questionnaire data and
DNA that passed quality control criteria for scanning. The controls
were never-smoking females matched by age (62 years) to cases.
Cluster definitions were determined using Illumina BeadStudio
Genotyping Module v.3.3.4. Genotype calls were based on a
quality score (Gene call value) of 0.25 or higher. Four blind
duplicate pairs were included, and the concordance of SNP
genotype calls between each pair is greater than 99.997%. Quality
control metrics for data from the first phase are similar to those for
data from the second phase, detailed below.
In the second phase of the GWAS, 550 cases and 549 controls
were genotyped with the Illumina HumanHap610 Quad BeadChip
on contract at deCODE Genetics, Iceland. The cases were the first
never-smoking female lung adenocarcinoma subjects to be enrolled
in the study with questionnaire data and DNA that passed quality
control for scanning. Cluster definitions were determined using the
Illumina BeadStudio Genotyping Module. The median genotype
call rate for samples was 99.78%. 95% overall displayed call rates
larger than 99.49%; the median call rate for variants is 99.91%, with
95% of variants with call rates above 99.55%. 21 blind duplicate
pairs displayed an average concordance greater than 99.99%.
After quality control metrics were applied, 457,504 SNPs were
used for the association analysis. SNPs (n=1,705) were excluded if
the call rate was below 90%, (i.e., a missing rate larger than 0.1);
SNPs with a minor allele frequency below 0.05 (n=131,558);
SNPs with missing rate between 0.02 and 0.1 and non-random
genotype failure with p,0.02 (n=1,046); and, significant devia-
tion from fitness for Hardy-Weinberg equilibrium (p,0.0001 in
controls) (n=718). 1064 unique samples from phase 2 were used
in the association analysis, after two exclusion steps. The first set of
exclusions was based on the quality control metrics described
above and relatedness among individuals: call rates less than 90%
(n=3); sex discrepancies based on the X chromosome heterozy-
gosity (n=7); contaminated samples with high heterozygosity
scores (n=4), first or second degree relatives identified using
genome-wide pairwise identical by descent (IBD) estimates (n=9).
We further excluded 12 individuals from phase 2, based on
population substructure analysis. In fact, to detect differences in
population substructure, pairwise population concordance (PPC) test
in PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) [36] were
performed with a threshold of 10
220 on two data sets using all
autosomal SNPs that had passed the quality control metrics des-
cribed above. The first data set consists of the 1184 unrelated indivi-
duals with high quality genotype data (108 from phase 1 and 1076
from phase 2). The PPC test identified 15 outliers who were distinct
from the remaining 1169 (105 from phase 1 and 1064 from phase 2).
The eight self-described aborigines (2 in Phase 1 and 6 in Phase 2)
were among the outliers. Based on the PPC analysis, the final
genome-wideassociationanalysiswasconductedusing1169samples.
To further assess the population homogeneity in our study
sample, we conducted additional analyses in our 1184 individuals
with HapMap3 release 2 data [37]. The results indicate that for
the 1184 unrelated individuals with high quality genotype data, 15
outliers were detected, thus yielding 1169 individuals with
homogeneous genetic structure available for follow-up analyses.
We seeded the study population with genotype data from hapmap
3 as well as hapmap 2; this included 85 CHD (Chinese in
Metropolitan Denver, Colorado), in addition to our 1184
individuals and the hapmap 2 (84 CHB (Han Chinese in Beijing,
China) and 86 JPT (Japanese in Tokyo, Japan)). A second analysis
included our 1184 study individuals and a larger sample of
HapMap3 release 2, namely the CHB, CHD, GIH (Gujarati
Indians in Houston, Texas), JPT, LWK (Luhya in Webuye,
Kenya), MKK (Maasai in Kinyawa, Kenya), and TSI (Toscani in
Italia): the results confirmed that 15 outliers were detected whereas
the 1164 represented a homogeneous population.
Although the above PPC tests seem to suggest little population
substructure in our 1169 samples, we still used EIGENSTRAT
[38] to conduct GWAS analysis to correct possible population
stratification. We found that for the SNP rs2736100, the P-value is
1.239610
211 based on the Armitage trend Chi-square statistic
with no stratification correction and the P-value is 2.764610
211
based on EIGENSTRAT using 10 principal components (the
default value) for stratification correction. There was a negligible
difference in p-values with and without this correction.
The genotyping cluster plot generated by the Illumina platform for
rs2736100 is presented in Figure S2. The adjusted intensities for each
allele are plotted, where each color represents a different genotype in
theclusterplots.Asshowninthefigure,clustersofdifferentgenotypes
are well separated from each other, indicating a high confidence in
genotype calling in our study. The genotype call at this locus was
confirmed with TaqMan genotyping (concordance of 99.7%).
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extracted from blood samples and genotyped at the National
Cancer Institute Core Genotyping Facility (CGF) (Http://cgf.nci.
nih.gov) for four studies, SNU, KUMC, KNUH, and SWHS.
TaqMan genotyping for the GELAC study (including all
previously scanned cases and controls plus remaining never-
smoking female cases and their matched controls) and the GEL-S
studies was conducted in Taiwan and Singapore, respectively.
Genotyping for the CAMSCH, WHLCS, and NJLCS studies were
conducted at the Cancer Institute and Hospital, Chinese Academy
of Medical Science, using TaqMan assays designed and optimized
by the CGF (http://snp500cancer.nci.nih.gov).
We selected 54 SNPs optimized for Eastern Asian populations
to cover the three chromosomal regions previously reported to
show association for lung cancer (i.e., 15 SNPs in 5p15, 15 SNPs in
6p, and 24 SNPs in 15q25) (Table S3). The coordinates for
selecting the tag SNPs were based on an r
2,0.8 using the CHB
samples of HapMap phase 2. The boundaries for the tag SNP
selection were as follows: 5p15.33 from 1310620 to 1412939,
6p21.33 from 28782776 to 29018856 and 15q25 from 76593077
to 76702301 (Build 37). We computed genomic coverage using the
GLU software package (http://code.google.com/p/glu-genetics/)
for common SNPs (MAF$0.05) based on the most recent build
(Build 37) of the HapMap CHB [37] genotype data.
All TaqMan assays (Applied Biosystems Inc., Foster City, CA)
for this study were optimized on the ABI 7900HT detection
system with high concordance with sequence analysis of 102
individuals as listed on the SNP500Cancer website (http://
snp500cancer.nci.nih.gov). All of the genotype frequencies were
consistent with Hardy-Weinberg equilibrium except three SNPs
(rs402710, rs9368570, and rs9257280) using a chi-square test
(P,0.0001, Table S3). All reported genotyped results are based on
completion rates of greater than 94% across all studies.
Statistical analysis
Genome-wide association tests. The program PLINK [36]
was used to conduct primary statistical tests for association in the
discovery phase. Association analyses between individual SNP and
the lung cancer risk were carried out using computer packages in
PLINK. Q-Q plots analyzed by the trend test are shown in
Figure 1. We note that for Phase 1, we imputed the genotypes at
the SNPs contained in HumanHap 610 Quad BeadChip but not
in HumanCNV370-Duo BeadChip by using IMPUTE developed
by Marchini et al. [39] and haplotypes of CHB in HapMap as the
reference.
Replication and pooled analyses. Unconditional logistic
regression was used to estimate the ORs and 95% CIs, adjusting for
age and study center.Allp valuesare two-sided. The most prevalent
homozygous genotype was used as the reference group. Tests for
trend were conducted by assigning the ordinal values 1, 2, and 3
to the most prevalent genotypes in rank order of wild type,
heterozygous, and variant homozygous genotypes, respectively.
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